Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing
Blog
Health Care Viewpoints
On February 26, 2019, the Senate Finance Committee heard testimony from top executives representing seven high-profile drug manufacturers. This…
Popular articles from this firm
